Why Concert Pharmaceuticals Stock Is Soaring Today
What happened Shares of Concert Pharmaceuticals (NASDAQ: CNCE) surged as much as 91.5% in morning trading on Monday as the result of a deal with Vertex Pharmaceuticals (NASDAQ: VRTX) for the experimental cystic fibrosis (CF) drug CTP-656. As of 11:45 a.m. EST, the stock has settled to a 72% gain. Per the terms of the deal,… Read More »